Vitamin D and breast cancer

Record ID 32013000214
Authors' recommendations: Women diagnosed with breast cancer typically have levels of vitamin D that are below the level considered sufficient for optimal health. Given the regulatory roles played by vitamin D for tumor control within breast tissue and for general bone health, vitamin D sufficiency may improve breast cancer outcomes as well as improve the safety and effectiveness of breast cancer treatments. Vitamin D testing measures the circulating levels of 25-hydroxyvitamin D (25-OHD), the molecule that best represents vitamin D status. Vitamin D supplementation is intended to improve circulating levels of 25-OHD.
Project Status: Completed
Year Published: 2012
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Vitamin D
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
Contact Email:
Copyright: 2012 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.